Literature DB >> 30888757

Rectal cancer surgery : what's in a name?

N Komen1, P Dewint2,3, S Van den Broeck1, S Pauli4, H de Schepper2.   

Abstract

The field of rectal cancer treatment is a dynamic and changing field, due to better understanding of the pathology and new medical treatment options, but perhaps mostly due to innovations in the surgical approach. Surgery is the cornerstone for rectal cancer treatment. Currently, Total Mesorectal Excision is the gold standard. After evolution towards laparoscopic TME, improving technology has led to the development of platforms that allow transanal TME and robotic TME. In addition, local excision can be performed safer and more accurately by means of Transanal Endoscopic Microsurgery (TEM), TransAnal Minimally Invasive Surgery or Endoscopic Submucosal Dissection (ESD), possibly avoiding TME. The aim of this review is to summarize the different surgical techniques and approaches for rectal cancer in function of tumor stage and describe the specifics of the technique. © Acta Gastro-Enterologica Belgica.

Entities:  

Keywords:  ESD; TAMIS; TEM; TME; TaTME; rectal cancer; surgery

Mesh:

Year:  2019        PMID: 30888757

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  4 in total

1.  MRI pelvimetry-based evaluation of surgical difficulty in laparoscopic total mesorectal excision after neoadjuvant chemoradiation for male rectal cancer.

Authors:  Jianhua Chen; Yanwu Sun; Pan Chi; Bin Sun
Journal:  Surg Today       Date:  2021-01-09       Impact factor: 2.549

2.  Apoptosis-Associated Gene Expression Profiling Is One New Prognosis Risk Predictor of Human Rectal Cancer.

Authors:  Qiansan Zhu; Xian Wu; Lili Ma; Haibo Xue
Journal:  Dis Markers       Date:  2022-04-23       Impact factor: 3.464

3.  Outcomes of robotic low anterior resection versus transanal total mesorectal excision for rectal cancer.

Authors:  J L B Buan; W Z So; X C Lim; C S Chong
Journal:  BJS Open       Date:  2021-09-06

4.  Low-Rank Matrix Denoising Algorithm-Based MRI Image Feature for Therapeutic Effect Evaluation of NCRT on Rectal Cancer.

Authors:  Qin Hu; Jin Li; Jun Li
Journal:  J Healthc Eng       Date:  2021-11-29       Impact factor: 2.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.